CA2459886A1 - 1-glyoxlylamide indolizines for treating cancer - Google Patents

1-glyoxlylamide indolizines for treating cancer Download PDF

Info

Publication number
CA2459886A1
CA2459886A1 CA002459886A CA2459886A CA2459886A1 CA 2459886 A1 CA2459886 A1 CA 2459886A1 CA 002459886 A CA002459886 A CA 002459886A CA 2459886 A CA2459886 A CA 2459886A CA 2459886 A1 CA2459886 A1 CA 2459886A1
Authority
CA
Canada
Prior art keywords
substituted
group
alkyl
unsubstituted
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002459886A
Other languages
English (en)
French (fr)
Inventor
Keizo Koya
Lijun Sun
Mitsunori Ono
Weiwen Ying
Hao Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synta Phamaceuticals Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2459886A1 publication Critical patent/CA2459886A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002459886A 2001-09-13 2002-09-13 1-glyoxlylamide indolizines for treating cancer Abandoned CA2459886A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32202001P 2001-09-13 2001-09-13
US60/322,020 2001-09-13
PCT/US2002/029154 WO2003022846A1 (en) 2001-09-13 2002-09-13 1-glyoxlylamide indolizines for treating cancer

Publications (1)

Publication Number Publication Date
CA2459886A1 true CA2459886A1 (en) 2003-03-20

Family

ID=23253054

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002459886A Abandoned CA2459886A1 (en) 2001-09-13 2002-09-13 1-glyoxlylamide indolizines for treating cancer

Country Status (19)

Country Link
US (2) US6861436B2 (enExample)
EP (1) EP1432709B8 (enExample)
JP (1) JP2005504795A (enExample)
KR (1) KR20040053125A (enExample)
CN (1) CN1568324A (enExample)
AT (1) ATE300542T1 (enExample)
AU (1) AU2002333626B2 (enExample)
BR (1) BR0212794A (enExample)
CA (1) CA2459886A1 (enExample)
DE (1) DE60205265T2 (enExample)
ES (1) ES2245747T3 (enExample)
IL (1) IL160810A0 (enExample)
IS (1) IS7176A (enExample)
MX (1) MXPA04002323A (enExample)
NO (1) NO20041035L (enExample)
NZ (1) NZ531700A (enExample)
PT (1) PT1432709E (enExample)
WO (1) WO2003022846A1 (enExample)
ZA (1) ZA200401996B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040116462A1 (en) * 2002-12-12 2004-06-17 Mitsunori Ono Indolizine compounds
PT1432709E (pt) * 2001-09-13 2005-10-31 Synta Pharmaceuticals Corp Indolizinas de 1-glioxilamida para o trtamento do cancro
JP2006504692A (ja) * 2002-09-13 2006-02-09 シンタ ファーマシューティカルズ コーポレーション インドリジンの合成方法
DE10318611A1 (de) 2003-04-24 2004-11-11 Elbion Ag 4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
WO2005099824A1 (en) * 2004-03-30 2005-10-27 Synta Pharmaceuticals, Corp. 1-glyoxylamide indolizines for treating lung and ovarian cancer
GB0413605D0 (en) 2004-06-17 2004-07-21 Addex Pharmaceuticals Sa Novel compounds
US20070293456A9 (en) * 2004-12-30 2007-12-20 Anthony Hayford Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds
WO2006128184A2 (en) * 2005-05-20 2006-11-30 Alantos-Pharmaceuticals, Inc. Pyrimidine or triazine fused bicyclic metalloprotease inhibitors
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
CA2733247C (en) * 2008-08-14 2018-04-03 Beta Pharma Canada Inc. Heterocyclic amide derivatives as ep4 receptor antagonists
EP4008327A1 (en) 2009-04-29 2022-06-08 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
AR077428A1 (es) * 2009-07-29 2011-08-24 Sanofi Aventis (aza) indolizinacarboxamidas ciclicas su preparacion y su uso como agentes farmaceuticos
CN113603694B (zh) * 2021-07-16 2022-07-22 浙江工业大学 一种1,2-二酮类化合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2287706A (en) * 1994-03-21 1995-09-27 Fujisawa Pharmaceutical Co Indolizine derivatives
FR2757166B1 (fr) * 1996-12-12 1999-01-29 Rhone Poulenc Rorer Sa Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
WO1998047507A1 (en) * 1997-04-24 1998-10-29 Shionogi & Co., Ltd. Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds
US6472389B1 (en) 1998-05-21 2002-10-29 Shionogi & Co., Ltd. Pyrrolo[1,2-b] pyridazine derivatives having sPLA2 inhibitory effect
CA2346334A1 (en) 1998-10-14 2000-04-20 Shionogi & Co., Ltd. Composition for treating or preventing ischemia reperfusion injury
US6461538B2 (en) * 1999-12-16 2002-10-08 Fuji Photo Film Co., Ltd. Production process for indolizine compounds and their use in organic light-emitting devices
PT1432709E (pt) * 2001-09-13 2005-10-31 Synta Pharmaceuticals Corp Indolizinas de 1-glioxilamida para o trtamento do cancro
US20040116462A1 (en) * 2002-12-12 2004-06-17 Mitsunori Ono Indolizine compounds

Also Published As

Publication number Publication date
IL160810A0 (en) 2004-08-31
NO20041035L (no) 2004-04-30
AU2002333626B2 (en) 2006-06-29
DE60205265T2 (de) 2006-03-30
KR20040053125A (ko) 2004-06-23
ZA200401996B (en) 2005-05-31
MXPA04002323A (es) 2005-04-08
EP1432709B1 (en) 2005-07-27
EP1432709A1 (en) 2004-06-30
US6861436B2 (en) 2005-03-01
JP2005504795A (ja) 2005-02-17
EP1432709B8 (en) 2005-11-02
IS7176A (is) 2004-03-11
ES2245747T3 (es) 2006-01-16
WO2003022846A1 (en) 2003-03-20
HK1063322A1 (en) 2004-12-24
DE60205265D1 (de) 2005-09-01
PT1432709E (pt) 2005-10-31
BR0212794A (pt) 2004-10-05
CN1568324A (zh) 2005-01-19
ATE300542T1 (de) 2005-08-15
US20030153759A1 (en) 2003-08-14
NZ531700A (en) 2006-10-27
US20040214850A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
RU2270194C2 (ru) Бензофеноны как ингибиторы il-1бета и tnf-альфа, фармацевтическая композиция и способ лечения
CN100436425C (zh) 稠合的咪唑衍生物
EP3129373B1 (en) Histone deacetylase inhibitors
CA2460345A1 (en) 2-aroylimidazole compounds for treating cancer
CA2459886A1 (en) 1-glyoxlylamide indolizines for treating cancer
CA3228411A1 (en) Sulfonamide derivative, preparation method therefor and medical use thereof
WO2007032466A1 (ja) 複素環化合物、その製造方法並びに用途
AU2002333626A1 (en) 1-glyoxlylamide indolizines for treating cancer
WO2014117676A1 (zh) 一种具有dhodh抑制活性的含n、s杂环化合物及其制备和用途
AU2002323474B2 (en) 3-glyoxlylamideindoles for treating cancer
CA2903646A1 (en) Novel sulfonamide trpa1 receptor antagonists
AU2002323474A1 (en) 3-glyoxlylamideindoles for treating cancer
JP7530510B2 (ja) Rnaヘリカーゼdhx33を阻害する多環式化合物及びその応用
CN107880038B (zh) [1,2,4]三唑并[1,5-a]吡啶类化合物及其制备方法和医药用途
JP2024528251A (ja) Hdacとnad合成を標的とする多標的阻害剤及びその用途
JP7624184B2 (ja) Ido/tdo阻害剤
EP1598352A1 (en) 1-Glyoxylamide indolizines for treating cancer
HK1079507A (en) 1-glyoxylamide indolizines for treating cancer
WO2023168908A1 (zh) 稠合的醌肟咪唑及其鎓衍生物与其制备和用途
HK1063322B (en) 1-glyoxylamide indolizines for treating cancer
JP2024009788A (ja) Ido/tdo阻害剤
CN109232517A (zh) 一组磺酰香豆素类衍生物及其在制备抗肿瘤药物中的应用

Legal Events

Date Code Title Description
FZDE Discontinued